Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Prognosis After Surgical Resection in Patients With Hepatocellular Carcinoma Combined Portal Vein Tumor Thrombosis; Multicenter Retrospective Study

NCT06005883 is registered in ClinicalTrials.gov with Keimyung University Dongsan Medical Center as lead sponsor.

NCT NCT06005883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06005883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Prognosis After Surgical Resection in Patients With Hepatocellular Carcinoma Combined Portal Vein Tumor Thrombosis; Multicenter Retrospective Study
Lead sponsor
Keimyung University Dongsan Medical Center
Phase
Observational
Overall status
Completed
Start date
April 10, 2021
Completion date
April 10, 2022
Enrollment
332 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma, portal vein thrombosis, prognosis